Assessing complications after skull base tumor surgery
Postoperative Complications Following Skull Base Tumor Resection: an Observational Study
This study is testing if using lung ultrasound can help find patients at risk for breathing problems and blood clots after surgery for skull base tumors.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 122 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Trial ID | NCT06587906 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the high incidence of postoperative complications following skull base tumor resections. It aims to evaluate the occurrence of pulmonary complications and lower extremity venous thrombosis in patients undergoing elective surgery. By utilizing pulmonary ultrasound, the study seeks to identify high-risk patients early and improve perioperative management. Data will be collected on the accuracy of lung ultrasound scores in predicting these complications within a week post-surgery.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and above who are undergoing elective resection of skull base tumors and have a physical status classified as I to III.
Not a fit: Patients with severe heart or lung diseases, or those unable to complete preoperative cardiac assessments, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and management of postoperative complications, enhancing patient outcomes.
How similar studies have performed: Previous studies have shown success in using pulmonary ultrasound for early detection of complications in surgical patients, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 and above * American Society of Anesthesiologists physical status I to III * Undergoing elective resection of skull base tumors * Obtaining written informed consent Exclusion Criteria: * Heart failure, myocarditis, pericarditis, and cardiomyopathy * Myocardial ischemia less than 6 months old * Severe arrhythmia * Severe bradycardia (heart rate below 50 beats per minute) * Unable to complete preoperative cardiac assessment * Severe liver dysfunction (Child Pugh C-grade) * Severe lung diseases
Where this trial is running
Beijing
- Beijing Tiantan Hospital, Capital Medical University — Beijing, China (Recruiting)
Study contacts
- Study coordinator: Yuming Peng
- Email: florapym766@163.com
- Phone: 18601076588
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.